文献速递骨质疏松与钙磷/甲状旁腺肥胖与代谢综合征

每周一次大剂量维生素D3补充对囊性纤维化成人肠道和气道微生物群的影响:双盲随机安慰剂对照临床试验

Bolus Weekly Vitamin D3 Supplementation Impacts Gut and Airway Microbiota in Adults With Cystic Fibrosis: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial.
PubMed 文献 · J Clin Endocrinol Metab · 2018-01-01

该双盲随机安慰剂对照试验纳入41例囊性纤维化成人,其中维生素D不足者23例随机接受每周口服50000 IU维生素D3或安慰剂共12周,维生素D充足者18例作为对照。结果显示肠道微生物群因维生素D状态不同而显著差异,补充维生素D3后肠道微生物组成发生变化,乳球菌属显著富集,而韦荣球菌属和丹毒丝菌科在安慰剂组富集。作者认为维生素D不足与微生物群改变相关,补充维生素D可能影响微生物群组成,但需进一步研究。

要点

  • 维生素D不足的囊性纤维化患者肠道中γ-变形菌纲(含潜在致病菌)显著富集。
  • 每周口服50000 IU维生素D3共12周后,肠道乳球菌属显著富集。
  • 安慰剂组肠道韦荣球菌属和丹毒丝菌科显著富集。

核心结论

  • 这项探索性研究提示,维生素D不足与微生物群组成改变相关,可能促进炎症,补充维生素D有潜力影响微生物群组成。
  • 需要额外研究来确定维生素D对微生物群的影响是否有利于囊性纤维化的临床结局。

研究设计与样本

  • 双盲、随机、安慰剂对照临床试验。
  • 41例囊性纤维化成人分为维生素D不足组(n=23)和维生素D充足组(n=18)。
  • 维生素D不足者随机接受每周口服50000 IU维生素D3或安慰剂,共12周。
  • 干预前后采集痰和粪便样本,使用Illumina MiSeq技术对16S核糖体RNA基因测序。

主要发现

  • 肠道微生物群因维生素D状态不同而显著差异,γ-变形菌纲在维生素D不足组富集。
  • 主坐标分析显示,维生素D不足患者接受安慰剂或维生素D3治疗12周后肠道微生物组成存在差异(置换多变量方差分析=0.024)。
  • 乳球菌属在维生素D3治疗组显著富集,而韦荣球菌属和丹毒丝菌科在安慰剂组显著富集。

关键数值与推荐

  • 维生素D不足定义为25-羟基维生素D < 30 ng/mL。
  • 维生素D不足者随机接受每周口服50000 IU维生素D3或安慰剂,共12周。
  • 主坐标分析组间差异的置换多变量方差分析=0.024。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Disruption of gut microbiota may exacerbate severity of cystic fibrosis (CF). Vitamin D deficiency is a common comorbidity in patients with CF that may influence composition of the gut microbiota. OBJECTIVES: Compare microbiota of vitamin D-sufficient and -insufficient CF patients and assess impact of a weekly high-dose vitamin D3 bolus regimen on gut and airway microbiome in adults with CF and vitamin D insufficiency (25-hydroxyvitamin D < 30 ng/mL). DESIGN: Forty-one subjects with CF were classified into two groups: vitamin D insufficient (n = 23) and vitamin D sufficient (n = 18). Subjects with vitamin D insufficiency were randomized to receive 50,000 IU of oral vitamin D3 or placebo weekly for 12 weeks. Sputum and stool samples were obtained pre- and postintervention and 16S ribosomal RNA genes sequenced using Illumina MiSeq technology. RESULTS: Gut microbiota differed significantly based on vitamin D status with Gammaproteobacteria, which contain numerous, potentially pathogenic species enriched in the vitamin D-insufficient group. Principal coordinates analysis showed differential gut microbiota composition within the vitamin D-insufficient patients following 12 weeks treatment with placebo or vitamin D3 (permutation multivariate analysis of variance = 0.024), with Lactococcus significantly enriched in subjects treated with vitamin D3, whereas Veillonella and Erysipelotrichaceae were significantly enriched in patients treated with placebo. CONCLUSION: This exploratory study suggests that vitamin D insufficiency is associated with alterations in microbiota composition that may promote inflammation and that supplementation with vitamin D has the potential to impact microbiota composition. Additional studies to determine the impact of vitamin D on microbiota benefit clinical outcomes in CF are warranted.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Kanhere M, He J, Chassaing B, et al. Bolus Weekly Vitamin D3 Supplementation Impacts Gut and Airway Microbiota in Adults With Cystic Fibrosis: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial. J Clin Endocrinol Metab. 2018. PMID: 29161417. doi:10.1210/jc.2017-01983

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。